| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acute liver injury, acute liver failure and acute on chronic liver failure: A clinical spectrum of poisoning due to Gyromitra esculenta
|
Arłukowicz-Grabowska, Magdalena
|
|
2019
|
18 |
3 |
p. 514-516
|
article
|
| 2 |
Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes
|
Aljumah, Abdulrahman A.
|
|
2019
|
18 |
3 |
p. 439-444
|
article
|
| 3 |
A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma
|
Piñero, Federico
|
|
2019
|
18 |
3 |
p. 480-487
|
article
|
| 4 |
Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)
|
Arab, Juan P.
|
|
2019
|
18 |
3 |
p. 518-535
|
article
|
| 5 |
AMH NEWSLETTER
|
|
|
2019
|
18 |
3 |
p. 517
|
article
|
| 6 |
An aqueous extract of Stevia rebaudiana variety Morita II prevents liver damage in a rat model of cirrhosis that mimics the human disease
|
Ramos-Tovar, Erika
|
|
2019
|
18 |
3 |
p. 472-479
|
article
|
| 7 |
Antioxidants benefits in hepatitis C infection in the new DAAs era
|
Lozano-Sepúlveda, Sonia A.
|
|
2019
|
18 |
3 |
p. 410-415
|
article
|
| 8 |
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study
|
Lionetti, Raffaella
|
|
2019
|
18 |
3 |
p. 434-438
|
article
|
| 9 |
Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment
|
Cano-Paniagua, Alejandra
|
|
2019
|
18 |
3 |
p. 501-507
|
article
|
| 10 |
Impact of sustained viral response in the evolution of minimal hepatic encephalopathy: A prospective pilot study
|
Hernández-Conde, Marta
|
|
2019
|
18 |
3 |
p. 429-433
|
article
|
| 11 |
Insurance status impacts treatment for hepatocellular carcinoma
|
Sobotka, Lindsay A.
|
|
2019
|
18 |
3 |
p. 461-465
|
article
|
| 12 |
Interaction of TM6SF2 E167K and PNPLA3 I148M variants in NAFLD in northeast China
|
Xu, Min
|
|
2019
|
18 |
3 |
p. 456-460
|
article
|
| 13 |
Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
|
Duarte, Sebastião M.B.
|
|
2019
|
18 |
3 |
p. 416-421
|
article
|
| 14 |
Pegylated interferon-α inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155
|
Zhang, Ying
|
|
2019
|
18 |
3 |
p. 494-500
|
article
|
| 15 |
Sofosbuvir-based antiviral therapy in patients with recurrent HCV infection after liver transplant: A real-life experience
|
Araujo, Alexandre
|
|
2019
|
18 |
3 |
p. 450-455
|
article
|
| 16 |
The basis of liver regeneration: A systems biology approach
|
Bhat, Mamatha
|
|
2019
|
18 |
3 |
p. 422-428
|
article
|
| 17 |
Transfer of peanut allergy from donor to recipient after liver transplant
|
Aggarwal, Avin
|
|
2019
|
18 |
3 |
p. 508-513
|
article
|
| 18 |
Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
|
Tovo, Cristiane V.
|
|
2019
|
18 |
3 |
p. 445-449
|
article
|
| 19 |
Treatment response in primary biliary cholangitis: The role of autoimmune hepatitis features
|
Mané, Fernando
|
|
2019
|
18 |
3 |
p. 488-493
|
article
|
| 20 |
Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population
|
Mazo, Daniel F.
|
|
2019
|
18 |
3 |
p. 466-471
|
article
|
| 21 |
Why, What and Where: 3W in hepatology
|
Tiribelli, Claudio
|
|
2019
|
18 |
3 |
p. 409
|
article
|
Journal description